Ajinomoto Co., Inc.
National Institute of Health Sciences.
J Toxicol Sci. 2020;45(10):599-609. doi: 10.2131/jts.45.599.
To assess the influences of blood sampling volumes or sites on toxicological and toxicokinetic (TK) evaluations, 4-week duration animal studies and a single-dose TK study of imipramine were conducted. In the toxicological evaluation, six-week-old Sprague-Dawley rats were divided into no blood and blood sampling groups. Fifty microliters (microsampling) or 100 μL (larger sampling) of blood/time point was collected from the jugular vein (50 μL of data was reported previously as Yokoyama et al., 2020) or the tail vein 6 to 7 times on days 1/2 and in week 4. Although no parameters were affected by the 100 μL sample from the tail vein, the 100 μL jugular vein sampling decreased the red blood cell parameters in females, possibly due to hemorrhage at the sampling site. Regarding the TK assessment, 50 μL of blood/site/time point was collected at 6 time points from the tail and jugular vein of the same male rats after single oral administration of 10 or 100 mg/kg imipramine, which was selected as a representative drug with high distribution volume. Although there were no differences in the AUC and C values between the sites, the plasma concentrations at the early time points were significantly lower from the tail vein than the jugular vein. From our studies, 50 μL of jugular and tail vein microsampling did not affect the toxicity parameters or AUC/C. However, appropriate toxicity considerations and/or selection of the blood sampling site may be important in the case of larger sampling volumes or blood concentration assessment.
为了评估采血体积或部位对毒理学和毒代动力学(TK)评估的影响,进行了为期 4 周的动物研究和单次剂量 TK 研究。在毒理学评价中,将 6 周龄 Sprague-Dawley 大鼠分为无采血组和采血组。从颈静脉(Yokoyama 等人先前报道的 50 μL 数据,2020 年)或尾静脉在第 1/2 天和第 4 周的 6 至 7 次采集 50 μL(microsampling)或 100 μL(较大采样)的血液/时间点。尽管 100 μL 尾静脉样本没有影响任何参数,但 100 μL 颈静脉采样降低了雌性动物的红细胞参数,可能是由于采血部位出血。关于 TK 评估,在单次口服 10 或 100 mg/kg 丙咪嗪后,在同一只雄性大鼠的尾静脉和颈静脉的 6 个时间点采集 50 μL/部位/时间点的血液,丙咪嗪被选为具有高分布体积的代表性药物。尽管 AUC 和 C 值在部位之间没有差异,但早期时间点从尾静脉的血浆浓度明显低于颈静脉。从我们的研究中可以看出,50 μL 颈静脉和尾静脉微量采血不会影响毒性参数或 AUC/C。然而,在较大的采血体积或血液浓度评估的情况下,适当的毒性考虑和/或采血部位的选择可能很重要。